Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells

Kai Chun Yang, Astrid Breitbart, Willem J. De Lange, Peter Hofsteen, Akiko Futakuchi-Tsuchida, Joy Xu, Cody Schopf, Maria V. Razumova, Alex Jiao, Robert Boucek, Lil Pabon, Hans Reinecke, Deok Ho Kim, J. Carter Ralphe, Michael Regnier, Charles E. Murry

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

A novel myosin heavy chain 7 mutation (E848G) identified in a familial cardiomyopathy was studied in patient-specific induced pluripotent stem cell–derived cardiomyocytes. The cardiomyopathic human induced pluripotent stem cell–derived cardiomyocytes exhibited reduced contractile function as single cells and engineered heart tissues, and genome-edited isogenic cells confirmed the pathogenic nature of the E848G mutation. Reduced contractility may result from impaired interaction between myosin heavy chain 7 and cardiac myosin binding protein C.

Original languageEnglish (US)
Pages (from-to)728-740
Number of pages13
JournalJACC: Basic to Translational Science
Volume3
Issue number6
DOIs
StatePublished - Dec 2018
Externally publishedYes

Keywords

  • disease-modeling
  • engineered heart tissue
  • genetic cardiomyopathy
  • induced pluripotent stem cells

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells'. Together they form a unique fingerprint.

Cite this